The weight-loss drugmaker's Wegovy and Ozempic are among the most closely watched new medications in recent history, but face ...

There is no shortage of warnings about the U.S. stock market’s high valuation, but a deeper look into sectors shows quite a ...

As it makes a name for itself and its custom, Dutch Bros-branded beverages, and if inflation moderates, its comps growth ...

Palantir stock is trading at a lofty valuation "which history suggests is nearly impossible to grow into," Deutsche Bank's ...

NICE has a narrow economic moat, but faces potential competition from AI entrants in the SMB segment. See why I rate the ...

However, this all hinges on which stocks you choose to buy -- putting your hard-earned money into subpar companies won't ...

Share prices of Microsoft (NASDAQ: MSFT) were down 6% immediately following its fiscal second-quarter earnings report on Jan.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

If there were any fears that spending on AI infrastructure was about to slow down, that was put to rest when Trump announced ...

Jabil's diversification in end markets, particularly Auto & Transportation and Healthcare & Packaging, is driving revenue ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.